Bacil Pharma Limited (BACPHAR.BO)
INR 60.12
(-1.99%)
INR 60.12
(-1.99%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.10 INR | 41.18% |
| 2022 | -0.17 INR | 97.4% |
| 2021 | -6.55 INR | -1497.56% |
| 2020 | -0.41 INR | 24.07% |
| 2019 | -0.54 INR | 6.9% |
| 2018 | -0.58 INR | 90.89% |
| 2017 | -6.37 INR | -181900.0% |
| 2016 | -0.00 INR | 96.82% |
| 2015 | -0.11 INR | -120.0% |
| 2014 | -0.05 INR | 73.68% |
| 2013 | -0.19 INR | -375.0% |
| 2012 | -0.04 INR | -157.14% |
| 2011 | 0.07 INR | 821.65% |
| 2010 | -0.01 INR | 75.57% |
| 2009 | -0.04 INR | 36.78% |
| 2008 | -0.06 INR | 0.0% |
| 2007 | - INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.06 INR | 16.13% |
| 2024 Q2 | 0.82 INR | 1521.14% |
| 2023 Q1 | 0.03 INR | 122.69% |
| 2023 Q4 | -0.07 INR | -66.18% |
| 2023 FY | - INR | 41.18% |
| 2023 Q2 | -0.02 INR | -166.1% |
| 2023 Q3 | -0.04 INR | -112.31% |
| 2022 Q1 | 0.04 INR | 100.63% |
| 2022 FY | - INR | 97.4% |
| 2022 Q2 | -0.01 INR | -115.75% |
| 2022 Q3 | -0.08 INR | -1100.0% |
| 2022 Q4 | -0.13 INR | -71.96% |
| 2021 Q3 | -0.04 INR | 71.23% |
| 2021 Q1 | -0.04 INR | 87.85% |
| 2021 Q2 | -0.13 INR | -224.19% |
| 2021 Q4 | -6.34 INR | -16851.87% |
| 2021 FY | - INR | -1497.56% |
| 2020 FY | - INR | 24.07% |
| 2020 Q1 | -0.01 INR | 72.97% |
| 2020 Q2 | -0.01 INR | 0.0% |
| 2020 Q3 | -0.05 INR | -400.0% |
| 2020 Q4 | -0.33 INR | -560.0% |
| 2019 Q3 | -0.42 INR | -2200.0% |
| 2019 Q2 | 0.02 INR | 122.22% |
| 2019 Q4 | -0.04 INR | 91.19% |
| 2019 FY | - INR | 6.9% |
| 2019 Q1 | -0.09 INR | -4.65% |
| 2018 Q1 | -0.16 INR | 97.53% |
| 2018 Q3 | -0.15 INR | 11.76% |
| 2018 Q2 | -0.17 INR | -6.25% |
| 2018 Q4 | -0.09 INR | 42.67% |
| 2018 FY | - INR | 90.89% |
| 2017 Q3 | -0.05 INR | 54.55% |
| 2017 Q1 | 0.22 INR | 214.29% |
| 2017 FY | - INR | -181900.0% |
| 2017 Q4 | -6.49 INR | -12880.0% |
| 2017 Q2 | -0.11 INR | -150.0% |
| 2016 Q1 | -0.08 INR | -867.0% |
| 2016 Q2 | 0.01 INR | 117.47% |
| 2016 FY | - INR | 96.82% |
| 2016 Q4 | 0.07 INR | 852.69% |
| 2016 Q3 | -0.01 INR | -169.4% |
| 2015 Q4 | 0.01 INR | 120.0% |
| 2015 FY | - INR | -120.0% |
| 2015 Q2 | -0.03 INR | 40.0% |
| 2015 Q1 | -0.05 INR | -455.56% |
| 2015 Q3 | -0.05 INR | -66.67% |
| 2014 Q4 | -0.01 INR | 10.0% |
| 2014 FY | - INR | 73.68% |
| 2014 Q2 | -0.01 INR | 66.67% |
| 2014 Q1 | -0.03 INR | 78.57% |
| 2014 Q3 | -0.01 INR | 0.0% |
| 2013 Q4 | -0.14 INR | -511.35% |
| 2013 FY | - INR | -375.0% |
| 2013 Q2 | -0.02 INR | -100.0% |
| 2013 Q3 | -0.02 INR | -14.5% |
| 2013 Q1 | -0.01 INR | 90.0% |
| 2012 Q2 | -0.06 INR | -133.68% |
| 2012 Q1 | 0.19 INR | 146.75% |
| 2012 Q3 | -0.07 INR | -4.22% |
| 2012 Q4 | -0.10 INR | -49.93% |
| 2012 FY | - INR | -157.14% |
| 2011 Q4 | 0.08 INR | 311.76% |
| 2011 FY | - INR | 821.65% |
| 2011 Q3 | 0.02 INR | 0.0% |
| 2010 FY | - INR | 75.57% |
| 2009 FY | - INR | 36.78% |
| 2008 Q4 | -0.06 INR | 0.0% |
| 2008 FY | - INR | 0.0% |
| 2007 Q4 | -0.00 INR | 0.0% |
| 2007 FY | - INR | 0.0% |